Sage Therapeutics to Report First Quarter 2023 Financial Results on Tuesday, May 2, 2023
April 18 2023 - 6:30AM
Business Wire
Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical
company leading the way to create a world with better brain health,
announced today that it will host a live webcast on Tuesday, May 2,
2023 at 8:00 a.m. ET to review first quarter 2023 financial results
and discuss recent business updates.
The webcast can be accessed on the Investor page of Sage’s
website at investor.sagerx.com. A replay of the webcast will be
available following the completion of the event and will be
archived for up to 30 days.
About Sage Therapeutics
Sage Therapeutics is a biopharmaceutical company fearlessly
leading the way to create a world with better brain health. Our
mission is to pioneer solutions to deliver life-changing brain
health medicines, so every person can thrive. For more information,
please visit. www.sagerx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230414005410/en/
Investor Contact Helen Rubinstein 315-382-3979
helen.rubinstein@sagerx.com Media Contact Matthew Henson
917-930-7147 matthew.henson@sagerx.com
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Aug 2024 to Sep 2024
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Sep 2023 to Sep 2024